These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1527427)

  • 1. Evaluation of human T cell lymphotropic virus infection in a cohort of injecting drug users.
    Palumbo PE; Weiss SH; McCreedy BJ; Alexander SS; Denny TN; Klein CW; Altman R
    J Infect Dis; 1992 Oct; 166(4):896-9. PubMed ID: 1527427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of human T-cell lymphotropic virus type 2 (HTLV-II) from people living in urban areas of Sao Paulo city: evidence of multiple subtypes circulation.
    Novoa P; Penalva de Oliveira AC; Posada Vergara MP; da Silva Duarte AJ; Casseb J
    J Med Virol; 2007 Feb; 79(2):182-7. PubMed ID: 17177305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
    Khabbaz RF; Hartel D; Lairmore M; Horsburgh CR; Schoenbaum EE; Roberts B; Hartley TM; Friedland G
    J Infect Dis; 1991 Feb; 163(2):252-6. PubMed ID: 1988509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
    Mangano AM; Remesar M; del Pozo A; Sen L
    J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-II among injecting drug users in Stockholm.
    Krook A; Blomberg J
    Scand J Infect Dis; 1994; 26(2):129-32. PubMed ID: 8036466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA; Zucker-Franklin D; Marmor M; Legler PM
    Proc Assoc Am Physicians; 1996 Nov; 108(6):444-8. PubMed ID: 8956367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.
    Ehrlich GD; Glaser JB; LaVigne K; Quan D; Mildvan D; Sninsky JJ; Kwok S; Papsidero L; Poiesz BJ
    Blood; 1989 Oct; 74(5):1658-64. PubMed ID: 2790192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994.
    Krook A; Albert J; Andersson S; Biberfeld G; Blomberg J; Eklund I; Engström A; Julander I; Käll K; Martin C; Stendahl P; Struve J; Sönnerborg A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug; 15(5):381-6. PubMed ID: 9342259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A.
    Vlahov D; Khabbaz RF; Cohn S; Galai N; Taylor E; Kaplan JE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):89-96. PubMed ID: 7712239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?
    Bassani S; Toro C; Jiménez V; Rodés B; Soriano V
    Clin Vaccine Immunol; 2006 Jan; 13(1):160-1. PubMed ID: 16426016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing.
    Kwok S; Gallo D; Hanson C; McKinney N; Poiesz B; Sninsky JJ
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):561-5. PubMed ID: 2187505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain.
    Calderón EJ; Rey C; Medrano FJ; Sánchez-Román J; Soriano V; Torres Y; Ruiz M; Lissen E; Leal M
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):686-90. PubMed ID: 8565986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil.
    Barcellos NT; Fuchs SC; Mondini LG; Murphy EL
    Sex Transm Dis; 2006 May; 33(5):302-6. PubMed ID: 16505751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
    Costa JM; Segurado AC
    J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Communication: Current Prevalence and Risk Factors Associated with Human T Lymphotropic Virus Type 1 and Human T Lymphotropic Virus Type 2 Infections Among HIV/AIDS Patients in São Paulo, Brazil.
    Caterino-de-Araujo A; Sacchi CT; Gonçalves MG; Campos KR; Magri MC; Alencar WK;
    AIDS Res Hum Retroviruses; 2015 May; 31(5):543-9. PubMed ID: 25464979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic features of HTLV-II: serologic and molecular evidence.
    Lowis GW; Sheremata WA; Minagar A
    Ann Epidemiol; 2002 Jan; 12(1):46-66. PubMed ID: 11750240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell leukemia virus (HTLV-I/II) serodiagnostic testing: disparate results among a cohort of intravenous drug users.
    Aboulafia DM; Feigal E; Vranzian K; Bennett C; Blattner W; Moss A; Slamon D
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1043-50. PubMed ID: 7904169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users.
    Briggs NC; Battjes RJ; Cantor KP; Blattner WA; Yellin FM; Wilson S; Ritz AL; Weiss SH; Goedert JJ
    J Infect Dis; 1995 Jul; 172(1):51-8. PubMed ID: 7797946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in detection of human T-cell leukemia viruses type I and type II infection.
    Rosenblatt JD; Zack JA; Chen IS; Lee H
    Nat Immun Cell Growth Regul; 1990; 9(3):143-9. PubMed ID: 2196457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.